Literature DB >> 3525745

Expression of the S-coded genes of lymphocytic choriomeningitis arenavirus using a baculovirus vector.

Y Matsuura, R D Possee, D H Bishop.   

Abstract

A DNA copy of the lymphocytic choriomeningitis virus (LCMV, WE strain)S RNA species has been inserted in both orientations into plasmids containing a 7.1 kb DNA sequence of the baculovirus Autographa californica nuclear polyhedrosis virus (AcNPV). The inserts were placed behind the polyhedrin gene promoter of AcNPV and in the place of the nucleotide sequences including and flanking the polyhedrin gene translation initiation codon. The derived plasmids were used to obtain recombinant AcNPV viruses after transfection of Spodoptera frugiperda cells in the presence of infectious AcNPV DNA and the selection of polyhedrin-negative viruses. The expression of the two LCMV S-coded genes, the nucleoprotein and glycoprotein precursor, in S. frugiperda cells by the recombinant baculoviruses is described. Based on the results obtained with three different expression vectors, the site of insertion of the foreign genes in the 5' non-coding region of the polyhedrin gene appears to be an important determinant of the level of expression obtained.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525745     DOI: 10.1099/0022-1317-67-8-1515

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference.

Authors:  W R Beyer; H Miletic; W Ostertag; D von Laer
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  Expression of eukaryotic genes in insect cultures.

Authors:  M J Fraser
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

3.  Expression of biologically active middle T antigen of polyoma virus from recombinant baculoviruses.

Authors:  J Forstová; N Krauzewicz; B E Griffin
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

4.  Immunological cross-reactions and interactions between the Drosophila melanogaster ref(2)P protein and sigma rhabdovirus proteins.

Authors:  F Wyers; P Dru; B Simonet; D Contamine
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Rabies diagnostic reagents prepared from a rabies N gene recombinant expressed in baculovirus.

Authors:  F L Reid-Sanden; J W Sumner; J S Smith; M Fekadu; J H Shaddock; W J Bellini
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

6.  Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D.

Authors:  H Ghiasi; A B Nesburn; R Kaiwar; S L Wechsler
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Expression of the Marek's disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV.

Authors:  M Niikura; Y Matsuura; D Endoh; M Onuma; T Mikami
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

8.  Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.

Authors:  Masayuki Saijo; Marie-Claude Georges-Courbot; Philippe Marianneau; Victor Romanowski; Shuetsu Fukushi; Tetsuya Mizutani; Alain-Jean Georges; Takeshi Kurata; Ichiro Kurane; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

9.  Characterization of monoclonal antibodies to Junin virus nucleocapsid protein and application to the diagnosis of hemorrhagic fever caused by South American arenaviruses.

Authors:  Mina Nakauchi; Shuetsu Fukushi; Masayuki Saijo; Tetsuya Mizutani; Agustín E Ure; Victor Romanowski; Ichiro Kurane; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

10.  Expression of the peplomer glycoprotein of murine coronavirus JHM using a baculovirus vector.

Authors:  S Yoden; T Kikuchi; S G Siddell; F Taguchi
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.